490 related articles for article (PubMed ID: 17611586)
21. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies.
Lamikanra A; Myers KA; Ferris N; Mitrophanous KA; Carroll MW
Gene Ther; 2005 Jun; 12(12):988-98. PubMed ID: 15772687
[TBL] [Abstract][Full Text] [Related]
22. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
[TBL] [Abstract][Full Text] [Related]
23. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
24. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
25. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors.
Zhang B; Xia HQ; Cleghorn G; Gobe G; West M; Wei MQ
Gene Ther; 2001 Nov; 8(22):1745-51. PubMed ID: 11892843
[TBL] [Abstract][Full Text] [Related]
26. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
[TBL] [Abstract][Full Text] [Related]
27. Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat.
Duisit G; Conrath H; Saleun S; Folliot S; Provost N; Cosset FL; Sandrin V; Moullier P; Rolling F
Mol Ther; 2002 Oct; 6(4):446-54. PubMed ID: 12377185
[TBL] [Abstract][Full Text] [Related]
28. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
29. Production and concentration of pseudotyped HIV-1-based gene transfer vectors.
Reiser J
Gene Ther; 2000 Jun; 7(11):910-3. PubMed ID: 10849549
[TBL] [Abstract][Full Text] [Related]
30. Optimized large-scale production of high titer lentivirus vector pseudotypes.
Sena-Esteves M; Tebbets JC; Steffens S; Crombleholme T; Flake AW
J Virol Methods; 2004 Dec; 122(2):131-9. PubMed ID: 15542136
[TBL] [Abstract][Full Text] [Related]
31. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography.
Scherr M; Battmer K; Eder M; Schüle S; Hohenberg H; Ganser A; Grez M; Blömer U
Gene Ther; 2002 Dec; 9(24):1708-14. PubMed ID: 12457285
[TBL] [Abstract][Full Text] [Related]
32. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
33. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells.
Indraccolo S; Minuzzo S; Feroli F; Mammano F; Calderazzo F; Chieco-Bianchi L; Amadori A
Gene Ther; 1998 Feb; 5(2):209-17. PubMed ID: 9578840
[TBL] [Abstract][Full Text] [Related]
34. Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
Miletic H; Fischer YH; Neumann H; Hans V; Stenzel W; Giroglou T; Hermann M; Deckert M; Von Laer D
Hum Gene Ther; 2004 Nov; 15(11):1091-100. PubMed ID: 15610609
[TBL] [Abstract][Full Text] [Related]
35. Newborn liver gene transfer by an HIV-2-based lentiviral vector.
Salani B; Damonte P; Zingone A; Barbieri O; Chou JY; D'Costa J; Arya SK; Eva A; Varesio L
Gene Ther; 2005 May; 12(10):803-14. PubMed ID: 15772691
[TBL] [Abstract][Full Text] [Related]
36. Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: an approach to complement brain dysfunctions.
Mordelet E; Kissa K; Calvo CF; Lebastard M; Milon G; van der Werf S; Vidal C; Charneau P
Gene Ther; 2002 Jan; 9(1):46-52. PubMed ID: 11850722
[TBL] [Abstract][Full Text] [Related]
37. HIV-1-derived lentiviral vectors and fetal route of administration on transgene biodistribution and expression in rhesus monkeys.
Jimenez DF; Lee CI; O'Shea CE; Kohn DB; Tarantal AF
Gene Ther; 2005 May; 12(10):821-30. PubMed ID: 15815706
[TBL] [Abstract][Full Text] [Related]
38. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
Beyer WR; Westphal M; Ostertag W; von Laer D
J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
[TBL] [Abstract][Full Text] [Related]
39. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
[TBL] [Abstract][Full Text] [Related]
40. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
